{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:41:16Z","timestamp":1774266076823,"version":"3.50.1"},"reference-count":51,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p>Over the past few decades, there has been a remarkable improvement in the survival of patients with thalassaemia in developed countries. Availability of safe blood transfusions, effective and accessible iron chelating medications, the introduction of new and non-invasive methods of tissue iron assessment and other advances in multidisciplinary care of thalassaemia patients have all contributed to better outcomes. This, however, may not be true for patients who are born in countries where the resources are limited. Unfortunately, transfusion-transmitted infections are still major concerns in these countries where paradoxically thalassaemia is most common. Moreover, oral iron chelators and MRI for monitoring of iron status may not be widely accessible or affordable, which may result in poor compliance and suboptimal iron chelation. All of these limitations will lead to reduced survival and increased thalassaemia-related complications and subsequently will affect the patient's quality of life. In countries with limited resources, together with improvement of clinical care, strategies to control the disease burden, such as public education, screening programmes and appropriate counselling, should be put in place. Much can be done to improve the situation by developing partnerships between developed countries and those with limited resources. Future research should also particularly focus on patient's quality of life as an important outcome of care.<\/jats:p>","DOI":"10.1136\/archdischild-2014-308112","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T02:19:47Z","timestamp":1440037187000},"page":"1051-1057","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Thalassaemia in children: from quality of care to quality of life"],"prefix":"10.1136","volume":"100","author":[{"given":"Ali","family":"Amid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine N","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali T","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,8,19]]},"reference":[{"key":"key-10.1136\/archdischild-2014-308112-1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nm0896-847","article-title":"Thalassemia\u2014a global public health problem","volume":"2","author":"Weatherall","year":"1996","journal-title":"Nat Med"},{"key":"key-10.1136\/archdischild-2014-308112-2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"key":"key-10.1136\/archdischild-2014-308112-3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2005-01-0313","article-title":"Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya","volume":"106","author":"Williams","year":"2005","journal-title":"Blood"},{"key":"key-10.1136\/archdischild-2014-308112-4","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1542\/peds.2005-0843","article-title":"Changes in the epidemiology of thalassemia in North America: a new minority disease","volume":"116","author":"Vichinsky","year":"2005","journal-title":"Pediatrics"},{"key":"key-10.1136\/archdischild-2014-308112-5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2141.2011.08742.x","article-title":"The challenge of haemoglobinopathies in resource-poor countries","volume":"154","author":"Weatherall","year":"2011","journal-title":"Br J Haematol"},{"key":"key-10.1136\/archdischild-2014-308112-6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9343(66)90039-8","article-title":"Thalassemia: the consequences of unbalanced hemoglobin synthesis","volume":"41","author":"Nathan","year":"1966","journal-title":"Am J Med"},{"key":"key-10.1136\/archdischild-2014-308112-7","doi-asserted-by":"crossref","first-page":"a011726","DOI":"10.1101\/cshperspect.a011726","article-title":"Pathophysiology and clinical manifestations of the \u03b2-thalassemias","volume":"2","author":"Nienhuis","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key-10.1136\/archdischild-2014-308112-8","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.3324\/haematol.2014.117408","article-title":"Hb S\/\u03b2+-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the \u03b2 locus control region","volume":"100","author":"Amid","year":"2015","journal-title":"Haematologica"},{"key":"key-10.1136\/archdischild-2014-308112-9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcmd.2007.11.006","article-title":"Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients","volume":"40","author":"Harteveld","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"key-10.1136\/archdischild-2014-308112-10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1182\/asheducation-2007.1.79","article-title":"Hemoglobin E syndromes","author":"Vichinsky","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key-10.1136\/archdischild-2014-308112-11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/GIM.0b013e3181fcb468","article-title":"Gene test review. Alpha-thalassemia","volume":"13","author":"Galanello","year":"2011","journal-title":"Genet Med"},{"key":"key-10.1136\/archdischild-2014-308112-12","doi-asserted-by":"crossref","first-page":"a011718","DOI":"10.1101\/cshperspect.a011718","article-title":"The molecular basis of \u03b1-thalassemia","volume":"3","author":"Higgs","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key-10.1136\/archdischild-2014-308112-13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2002-07-1975","article-title":"Hemoglobin H disease: not necessarily a benign disorder","volume":"101","author":"Chui","year":"2003","journal-title":"Blood"},{"key":"key-10.1136\/archdischild-2014-308112-14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.1136\/archdischild-2014-308112-15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/CBO9780511596582.024","article-title":"Clinical aspects of \u03b2 thalassemia and related disorders (Chapter 17)","volume-title":"Disorders of hemoglobin. Genetics, pathophysiology, and clinical management","author":"Olivieri","year":"2009","edition":"2"},{"key":"key-10.1136\/archdischild-2014-308112-16","volume-title":"Guidelines for the clinical management of thalassaemia","author":"Cappellini","year":"2008","edition":"2"},{"key":"key-10.1136\/archdischild-2014-308112-17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199506013322202","article-title":"Clinical outcomes after transfusion-associated hepatitis C","volume":"332","author":"Tong","year":"1995","journal-title":"N Engl J Med"},{"key":"key-10.1136\/archdischild-2014-308112-18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.physiol.69.031905.164337","article-title":"Iron homeostasis","volume":"69","author":"Andrews","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"key-10.1136\/archdischild-2014-308112-19","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"key-10.1136\/archdischild-2014-308112-20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat Genet"},{"key":"key-10.1136\/archdischild-2014-308112-21","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1182\/blood-2006-09-048868","article-title":"Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin","volume":"109","author":"Gardenghi","year":"2007","journal-title":"Blood"},{"key":"key-10.1136\/archdischild-2014-308112-22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","article-title":"Beta-thalassemia","volume":"353","author":"Rund","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.1136\/archdischild-2014-308112-23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/bjh.13374","article-title":"Estimating tissue iron burden: current status and future prospects","volume":"170","author":"Wood","year":"2015","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"key-10.1136\/archdischild-2014-308112-24","first-page":"249","article-title":"Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).","volume":"2","author":"De Sanctis","year":"2004","journal-title":"Ped Endocrinol Rev"},{"issue":"(Suppl 1)","key":"key-10.1136\/archdischild-2014-308112-25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000064766","article-title":"Growth and puberty and its management in thalassaemia","volume":"58","author":"De Sanctis","year":"2002","journal-title":"Horm Res"},{"key":"key-10.1136\/archdischild-2014-308112-26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.blre.2007.10.001","article-title":"Advances in the allogeneic transplantation for thalassemia","volume":"22","author":"Lucarelli","year":"2008","journal-title":"Blood Rev"},{"key":"key-10.1136\/archdischild-2014-308112-27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"N Engl J Med"},{"key":"key-10.1136\/archdischild-2014-308112-28","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood-2003-08-2800","article-title":"New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years","volume":"104","author":"Sodani","year":"2004","journal-title":"Blood"},{"key":"key-10.1136\/archdischild-2014-308112-29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1472-6963-13-45","article-title":"Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program","volume":"13","author":"Sruamsiri","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"key-10.1136\/archdischild-2014-308112-30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","article-title":"The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization","volume":"41","author":"World Health Organization","year":"1995","journal-title":"Soc Sci Med"},{"key":"key-10.1136\/archdischild-2014-308112-31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1196\/annals.1345.035","article-title":"Quality of life in thalassemia","volume":"1054","author":"Telfer","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.1136\/archdischild-2014-308112-32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000057633","article-title":"Impact of thalassemia major on patients and their families","volume":"107","author":"Caro","year":"2002","journal-title":"Acta Haematologica"},{"key":"key-10.1136\/archdischild-2014-308112-33","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajh.23506","article-title":"Pregnancy outcomes in women with thalassemia in North America and the United Kingdom","volume":"88","author":"Thompson","year":"2013","journal-title":"Am J Hematol"},{"key":"key-10.1136\/archdischild-2014-308112-34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1471-6712.2004.00267.x","article-title":"Factors associated with the attitudes and expectations of patients suffering from beta-thalassaemia: a cross-sectional study","volume":"18","author":"Vardaki","year":"2004","journal-title":"Scand J Caring Sci"},{"key":"key-10.1136\/archdischild-2014-308112-35","doi-asserted-by":"crossref","first-page":"297641","DOI":"10.1155\/2012\/297641","article-title":"Health-related quality of life, treatment satisfaction, adherence and persistence in beta-thalassemia and myelodysplastic syndrome patients with iron overload receiving deferasirox: results from the EPIC clinical trial","volume":"2012","author":"Porter","year":"2012","journal-title":"Anemia"},{"key":"key-10.1136\/archdischild-2014-308112-36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajh.21896","article-title":"Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms","volume":"86","author":"Sobota","year":"2011","journal-title":"Am J Hematol"},{"key":"key-10.1136\/archdischild-2014-308112-37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjh.12631","article-title":"Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major","volume":"164","author":"Klaassen","year":"2014","journal-title":"Br J Haematol"},{"key":"key-10.1136\/archdischild-2014-308112-38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2326-10-1","article-title":"Factors affecting health-related quality of life in Thai children with thalassemia","volume":"10","author":"Thavorncharoensap","year":"2010","journal-title":"BMC Blood Disord"},{"key":"key-10.1136\/archdischild-2014-308112-39","first-page":"2165","article-title":"Anxiety, depression and quality of life in patients with beta thalassemia major and their caregivers","volume":"7","author":"Yengil","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"key-10.1136\/archdischild-2014-308112-40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbmt.2010.09.011","article-title":"Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation","volume":"17","author":"Caocci","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"key-10.1136\/archdischild-2014-308112-41","doi-asserted-by":"crossref","first-page":"a013482","DOI":"10.1101\/cshperspect.a013482","article-title":"\u03b2-thalassemia intermedia: a clinical perspective","volume":"2","author":"Musallam","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key-10.1136\/archdischild-2014-308112-42","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","article-title":"Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study","volume":"115","author":"Taher","year":"2010","journal-title":"Blood M"},{"key":"key-10.1136\/archdischild-2014-308112-43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2141.2010.08486.x","article-title":"Optimal management of beta thalassaemia intermedia","volume":"152","author":"Taher","year":"2011","journal-title":"Br J Haematol"},{"key":"key-10.1136\/archdischild-2014-308112-44","volume-title":"Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT)","author":"Taher","year":"2013","edition":"1"},{"key":"key-10.1136\/archdischild-2014-308112-45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0609.2011.01623.x","article-title":"Health-related quality of life in adults with transfusion-independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights","volume":"87","author":"Musallam","year":"2011","journal-title":"Eur J Haematol"},{"key":"key-10.1136\/archdischild-2014-308112-46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2190\/PM.44.4.a","article-title":"Prevalence of depression and anxiety in adult patients with beta-thalassemia major and intermedia","volume":"44","author":"Khoury","year":"2012","journal-title":"Int J Psychiatry Med"},{"key":"key-10.1136\/archdischild-2014-308112-47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MPH.0b013e3180437e02","article-title":"Thalassemia in Iran: epidemiology, prevention, and management","volume":"29","author":"Abolghasemi","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"key-10.1136\/archdischild-2014-308112-48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0950-3536(98)80076-0","article-title":"Prenatal diagnosis and screening of the haemoglobinopathies","volume":"11","author":"Cao","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"key-10.1136\/archdischild-2014-308112-49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000016129","article-title":"The history of community genetics: the contribution of the haemoglobin disorders","volume":"1","author":"Modell","year":"1998","journal-title":"Community Genet"},{"key":"key-10.1136\/archdischild-2014-308112-50","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/bmj.329.7475.1134","article-title":"Iranian national thalassaemia screening programme","volume":"329","author":"Samavat","year":"2004","journal-title":"BMJ"},{"key":"key-10.1136\/archdischild-2014-308112-51","doi-asserted-by":"crossref","DOI":"10.1002\/9780470696705","volume-title":"The thalassaemia syndromes.","author":"Weatherall","year":"2001","edition":"4"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2014-308112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:53:08Z","timestamp":1601117588000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2014-308112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,19]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,10,19]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1136\/archdischild-2014-308112"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2014-308112","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,19]]}}}